Science and technology of bioadhesive-based targeted oral delivery systems

Pharmaceutical Technology

Volumn 32, Issue 11, 2008, Pages 100-121

  Nangia, Avinash ^a  

^a Senior Vice president of Research and Development at Spherics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOADHESIVE; BIOADHESIVE POLYMERS; ORAL DELIVERIES; RELEASE KINETICS; SCIENCE AND TECHNOLOGIES; TARGETED DRUG DELIVERIES;

DRUG DELIVERY;

DRUG DOSAGE;

AMOXICILLIN; CARBIDOPA PLUS LEVODOPA; CARBOMER; CARBOXYMETHYLCELLULOSE; CHITOSAN; EUDRAGIT RS; FUROSEMIDE; GLIADIN; GRISEOFULVIN; ITRACONAZOLE; MUCIN; NANOPARTICLE; PACLITAXEL; PARACETAMOL; POLOXAMER; POLYANHYDRIDE; POLYCARBOPHIL; POLYMER; PRAMIPEXOLE; SPHEROMERS; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT; HUMAN; NONHUMAN; REVIEW;

EID: 59449089068     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. J.W. Lee, T.H. Park, and J.R. Robinson, "Bioadhesive-Based Dosage Forms: The Next Generation,"J. Pharm. Sci. 89, 850-866 (2000).
2. M.A. Longer, H.S. Ch'ng, and J.R. Robinson, "Bioadhesive Polymers as Platforms for the Oral Controlled Drug Delivery III. Oral Delivery of Chlorthiazide using a Bioadhesive Polymer," J. Pharm. Sci. 70, 406-411 (1985).
3. M.R. Jimenez-Castellanos, H. Zia, and C.T. Rhodes, "Mucoadhesive Drug Delivery Systems," Drug Dev. Ind. Pharm. 19, 143-194 (1993).
4. H.E. Junginger, "Bioadhesive Polymer Systems for Peptide Delivery," Acta Pharm. Technol. 36, 110-126 (1990).
5. J. Woodley, "Bioadhesion: New Possibilities for Drug Administration?" Clin. Pharmacokinet. 40, 77-84 (2001).
6. A. Bernkop-Schnurch and G. Walker, "Multifunctional Matrices for Oral Peptide Delivery," Crit. Rev. Drug Carrier Syst. 18, 459-501 (2001).
7. J.C. Richardson et al., "Oesophageal Bioadhesion of Sodium Alginate Suspensions, Particle Swelling and Mucosal Retention," Eur. J. Pharm. Sci. 23, 49-56 (2004).
8. D.S. Jones, A.D. Woolfson, and A.F. Brown, "Viscoelastic Properties of Bioadhesive, Chlorhexidine Containing Semisolids for Topical Application to the Oropharynx," Pharm. Res. 15, 1131-1136 (1998).
9. M.K. Chourasia and S.K. Jain, "Pharmaceutical Approaches to Colon Targeted Delivery Systems," J. Pharm. Pharmacol. 6, 33-66 (2003).
10. A. Nangia, "Bioadhesives for Targeted Oral Drug Delivery," Drug Delivery Report (summer) 46-54 (2006).
11. H.H. Sigurdsson, T. Loftsson, and C. Lehy, "Assessment of Mucoadhesion by a Resonant Mirror Biosensor," Int. J. Pharm. 325, 75-81 (2006).
12. J.D. Smart, "The Basics and Underlying Mechanisms of Mucoadhesion," Adv. Drug Delivery Reviews 57, 1556-1568 (2005).
13. A. Rubinstein and B. Tirosh, "Mucus Gel Thickness and Turnover in the Gastrointestinal Tract of the Rat: Response to Cholinergic Stimulus and Implication for Mucoadhesion," Pharm. Res. 11, 794-799 (1994).
14. M. Sakkinen et al., "Gramma-Scintigraphic Evaluation of the Fate of Macrocrystalline Chitosan Granules in Human Stomach," Eur. J. Pharm. Biopharm. 157, 133-143 (2004).
15. M. Säkkinen et al., "Evaluation of Microcrystalline Chitosan for Gastro-Retentive Drug Delivery," Eur. J. Pharm. Sci. 19, 345-353 (2003).
16. N.A. Peppsa and Y. Huang, "Nanoscale Technology through Muco- adhesive Interactions," Adv. Drug Del. Rev. 56, 1675-1678 (2004).
17. S.A. Mortazavi and J.D. Smart, "An In Vitro Method for Assessing the Duration of Mucoadhesion," J. Controlled Release 31, 207-212 (1994).
18. D.E. Chickering and E. Mathiowitz, "Definitions, Mechanism, and Theories of Bioadhesion," in Bioadhesive Drug Delivery System, E. Mathiowitz, D.E. Chickering, CM. Lehr, Eds. (Marcel Dekker, New York, NY, 1999), pp. 1-10.
19. C.A. Santos et al., "Poly(fumaric-co-sebacic anhydride): A Degradation Study as Evaluated by FTIR, DSC, GPC, and X-ray Diffraction," J. Controlled Release 60, 11-22 (1999).
20. A.A. Mortazavi and H.R. Moghimi, "The Effect of Hydroxyl Containing Tablet Excipients on the Adhesive Duration of Some Mucoadhesive Polymers," DARU 12, 11-17 (2004).
21. M.J. Tobyn, J.R. Johnson, and P.W. Dettmar, "Factors Affecting In Vitro Gastric Mucoadhesion: Influence of Tablet Excipients, Surfactants and Aalts on the Observed Mucoadhesion of Polymers," Eur. J. Pharm. Biopharm. 43, 65-71 (1997)
22. S. B. Bredenberg et al., "In Vitro and In Vivo E valuation of a New Sublingual Tablet System for Rapid Oromucosal Absorption using Fentanyl Citrate as the Active Substance," Eur. J. Pharm. Sci. 20, 327-334 (2003).
23. D.J. Debrozsi, R.L. Smith, and A.A. Sakr, "Comparative Mucoretention of Sucralfate Suspension in an Everted Rat Esophageal Model," Int. J. Pharm. 189, 81-89 (1999).
24. A.M. Potts et al., "Oesophageal Bandaging: A New Opportunity for Thermosetting Polymers," STP Pharm. Sci. 10, 293-301 (2000).
25. H. Batchelor, "Bioadhesive Dosage Forms for Esophageal Drug Delivery," Pharm. Res. 22, 175-181 (2005).
26. L. Zhang and H.K. Batchelor, "A Bioadhesive Formulation for the Delivery of Antifungal Agents to Oesophagus," J. Pharm. Pharmacol. 56, 44 (2004).
27. H. Nagano et al., "Preparation of Magnetic Granules Containing Bleomycin and Its Evaluation using Model Esophageal Cancer," Int. J. Pharm. 147, 119-125 (1997).
28. J.C. Richardson et al., "Oesophageal Bioadhesion of Sodium Alginate Suspensions 2. Suspension Behavior on Oesophageal Mucosa," Eur. J. Pharm. Sci. 24, 107-114 (2005).
29. S. Collaud et al., "Clinical Evaluation of Bioadhesive Hydrogels for Topical Delivery of Hexylaminolevulinate to Barrett's Esophagus," J. Controlled Release 123, 203-210 (2007).
30. H. Al-Dujaili, A.T. Florence, and E.G. Salole, "The Adhesiveness of Proprietary Tablets and Capsules to Porcine Oesophageal Tissue," Int. J. Pharm. 34, 75-79 (1986).
31. K.M. Tur, H.S. Ch'ng, and S. Baie, "Use of Bioadhesive Polymers to Improve the Bioavailability of Griseofulvin," Int. J. Pharm. 148, 63-71 (1997).
32. D. Harris et al., "GI Transit of Potential Bioadhesive Formulations in Man: A Scintigraphic Study," J. Controlled Release 12, 45-53 (1990).
33. G. Santus et al., "An In Vitro-In Vivo Investigation of Oral Bioadhesive Controlled Release Furosemide Formulations," Eur. J. Pharm. Biopharm. 44, 39-52 (1997).
34. J. Jacob et al., "Prolonged Upper GI Residence Time in Dogs of Bioadhesive-Coated Spheres," in Proceedings of CRS Annual Meeting (2003).
35. P. Moslemy et al., "Pharmacokinetic Studies with a Mucoadhesive Multilayer Extended Release Tablet Formulation of Levodopa-Car-bidopa in Fed and Fasted Beagles," CRS International Symposium on Bioactive Materials, Abstract #2502 (2007).
36. P. Moslemy et al, "Pharmacokinetic Studies with a Mucoadhesive Multilayer Extended Release Tablet Formulation of Levodopa-Carbidopa in Healthy Volunteers" in Proceedings of CRS Annual Meeting, Abstract #2499 (2007).
37. D.K. Haswani et al., "Pharmacokinetic Evaluation of Extended Release and Immediate Release Formulations of Pramipexole," CRS International Symposium on Bioactive Materials, Abstract #2104 (2007).
38. L. Yang, J.S. Chu, and J.A. Fix, "Colon-Specific Drug Delivery: New Approaches and In Vitro-In Vivo Evaluation," Int. J. Pharm. 235, 1-15 (2002).
39. J. Kopecek et al., "Polymers for Colon-Specific Drug Delivery," J. Controlled Release 19, 121-130 (1992).
40. A. Tursi et al., "Assessment of Orocaecal Transit Time in Different Localization of Crohn's Disease and Its Possible Influence on Clinical Response in Therapy," Eur. J. Gastroenterol. Hepatol. 15, 69-74 (2003).
41. C.K. Kim et al., "Trials of In Situ-Gelling and Mucoadhesive Acetaminophen Liquid Suppository in Human Subjects," Int. J. Pharm. 174, 201-207 (1998).
42. R. Yahagi, H. Onishi, and Y. Machida, "Preparation and Evaluation of Double-Phased Mucoadhesive Suppositories of Lidocaine Utilizing Carbopol and White Beeswax," J. Controlled Release 61, 1-8 (1999).
43. R. Yahagi et al., "Mucoadhesive Suppository of Ramosetron Hydrochloride Utilizing Carbopol.," Int. J. Pharm. 193, 205-212. (2000).
44. C.S. Yong et al., "Physicochemical Characterization and In Vivo Evaluation of Poloxamer-Based Solid Suppository Containing Diclofenac Sodium in Rats," Int. J. Pharm. 301, 54-61 (2005).
45. H.G. Choi, Y.K. Oh, and C.K. Kim, "In Situ Gelling and Mucoadhesive Liquid Suppository Containing Acetaminophen: Enhanced Bioavailability," Int. J. Pharm. 165, 23-32 (1998).
46. M. Tang, P. Dettmar, and H. Batchelor, "Bioadhesive Oesophageal Bandages: Protection Against Acid and Pepsin Injury," Int. J. Pharm. 292, 169-177 (2005).
47. H.K. Batchelor et al., "Feasibility of a Bioadhesive Drug Delivery System Targeted to Esophageal Tissue," Eur. J. Pharm. Biopharm. 57, 295-298 (2004).
48. V. Vonarx et al., "Potential Efficacy of a Delta 5-Aminolevulinic Acid Bioadhesive Gel Formulation for the Photodynamic Treatment of Lesions of the Gastrointestinal Tract in Mice," J. Pharm. Pharmacol. 49, 652-656 (1997).
49. A.M. Potts et al., "Oesophageal Bandaging: A New Opportunity for Thermosetting Polymers," STP Pharma. Sci. 10, 293-301 (2001).
50. G. Ponchel, "Mucoadhesion of Colloidal Particulate Systems in the Gastrointestinal Tract," Eur. J. Pharm. Biopharm. 44, 25-31 (1997).
51. J.K. Vasir, K. Tambwekar, and S. Garg, "Bioadhesive Microspheres as a Controlled Drug Delivery System," Int. J. Pharm. 255, 13-32 (2003).
52. C.A. Santos et al., "Correlation of Two Bioadhesion Assays: The Everted Sac Technique and the CAHN Microbalance," J. Controlled Release 61, 113-122 (1999).
53. A. Lamprecht, U. Schafer, and C.M. Lehr, "Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carrier to the Inflamed Colonic Mucosa," Pharm. Res. 18, 788-793 (2001).
54. K. Park and J.R. Robinson, "Bioadhesive Polymers as Platforms for Oral-Controlled Drug Delivery: Method to Study Bioadhesion," Int. J. Pharm. 19, 107-127 (1984).
55. S. Thairs et al., "Effect of Dose Size, Food and Surface Coating on the Gastric Residence and Distribution of an Ion Exchange Resin," Int. J. Pharm. 176, 47-53 (1998).
56. S. Furtado et al., "Oral Delivery of Insulin-Loaded Poly(fumaric-co-sebacic) Anhydride Microspheres," Int. J. Pharm. 347, 149-155 (2008).
57. M. Kreitz et al., "A Bioadhesive Nanoparticle Formulation for Improved Oral Delivery of Paclitaxel," in Proceedings of the Controlled Release Society's Annual Meeting (2004).
58. R.B. Umamaheshwari, S. Ramteke, and N.K. Jain, "Anti-Helicobacter Pylori Effect of Mucoadhesive Nanoparticles Bearing Amoxicillin in Experimental Gerbils Model," AAPS Pharm Sci. Tech. 5, 1-9 (2004).
59. A. Ahmed, C. Bonner and T.A. Desai, "Bioadhesive Microdevices with Multiple Reservoirs: A New Platform for Oral Drug Delivery," J. Controlled Release 81, 291-306 (2002)
60. S.L. Tao, M.W. Lubeley, and T.A. Desai, "Bioadhesive Poly(methyl methacrylate) Microdevices for Controlled Drug Delivery," J. Controlled Release 88, 215-228 (2003).
61. G.V. Betageri, D.V. Deshmukh, and R.B. Gupta, "Oral Sustained Release Bioadhesive Tablet Formulations of Didanosine," Drug Dev. Ind. Pharm. 27, 129-136 (2001).
62. A. Bernkop-Schnürch et al., "The Use of Thiolated Polymers as Carrier Matrix in Oral Peptide Delivery: Proof of Concept," J. Controlled Release 106, 26-33 (2005).
63. A. Nangia, "BIOROD Bioadhesive Based Oral Delivery System," Annual CRS International Symposium on Bioactive Materials, New York (2008) submitted abstract.
64. J.A. Champion, Y.K. Katare, and S. Mitragotri, "Particle Shape: A New Design Parameters for Micro- and Nanoscale Drug Delivery Carriers," J. Controlled Release 121, 3-9 (2007).
65. R. Khosla and S.S. David, "The Effect of Polycarbophil on the Gastric Emptying of Pellets," J. Pharm. Pharmacol 39, 47-49 (1987).
66. S.J. Jackson, D. Bush, and A.C. Perkins, "Comparative Scintigraphic Assessment of Intragastric Distribution and Residence of Cholestyramine, Carbopol 934P, and Sucralfate," Int. J. Pharm. 212, 55-62 (2001).
67. J. Jacob et al., "Single Dose Pharmacokinetics of Bioadhesive Itraconazole Tablets (Spherazole) in Healthy Volunteers," CRS International Symposium on Bioactive Materials, Abstract #770 (2005).
68. J. Jacob et al., "Gastroretentive, Bioadhesive Drug Delivery System for Controlled Release of Itraconazole: Pharmacokinetics of Spherazole CR in Healthy Human Volunteers," J. Clin. Pharmacol. 46, 1065 (2006). PT